Insider Transactions in Q1 2021 at Adaptive Biotechnologies Corp (ADPT)
Insider Transaction List (Q1 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 26
2021
|
Stacy L Taylor SVP and General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
2,812
+30.44%
|
$19,684
$7.18 P/Share
|
|
Feb 26
2021
|
Julie Rubinstein President |
SELL
Open market or private sale
|
Direct |
15,000
-100.0%
|
$840,000
$56.23 P/Share
|
|
Feb 26
2021
|
Julie Rubinstein President |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+50.0%
|
$90,000
$6.55 P/Share
|
|
Feb 25
2021
|
Julie Rubinstein President |
SELL
Open market or private sale
|
Direct |
14,675
-97.96%
|
$821,800
$56.73 P/Share
|
|
Feb 25
2021
|
Julie Rubinstein President |
BUY
Exercise of conversion of derivative security
|
Direct |
14,675
+50.0%
|
$88,050
$6.55 P/Share
|
|
Feb 24
2021
|
Julie Rubinstein President |
SELL
Open market or private sale
|
Direct |
15,000
-54.37%
|
$855,000
$57.91 P/Share
|
|
Feb 24
2021
|
Julie Rubinstein President |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+50.0%
|
$90,000
$6.55 P/Share
|
|
Feb 23
2021
|
Julie Rubinstein President |
SELL
Open market or private sale
|
Direct |
15,000
-54.04%
|
$825,000
$55.25 P/Share
|
|
Feb 23
2021
|
Julie Rubinstein President |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+50.0%
|
$90,000
$6.55 P/Share
|
|
Feb 22
2021
|
Julie Rubinstein President |
SELL
Open market or private sale
|
Direct |
15,000
-70.76%
|
$900,000
$60.67 P/Share
|
|
Feb 22
2021
|
Julie Rubinstein President |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+50.0%
|
$90,000
$6.55 P/Share
|
|
Feb 19
2021
|
Sharon Benzeno Chief Commercial Ofc Imm Med |
SELL
Open market or private sale
|
Direct |
416
-100.0%
|
$25,376
$61.2 P/Share
|
|
Feb 19
2021
|
Sharon Benzeno Chief Commercial Ofc Imm Med |
BUY
Exercise of conversion of derivative security
|
Direct |
416
+50.0%
|
$2,496
$6.27 P/Share
|
|
Feb 19
2021
|
Julie Rubinstein President |
SELL
Open market or private sale
|
Direct |
15,000
-63.45%
|
$930,000
$62.27 P/Share
|
|
Feb 19
2021
|
Julie Rubinstein President |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+50.0%
|
$90,000
$6.55 P/Share
|
|
Feb 18
2021
|
Julie Rubinstein President |
SELL
Open market or private sale
|
Direct |
15,000
-69.64%
|
$900,000
$60.85 P/Share
|
|
Feb 18
2021
|
Julie Rubinstein President |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+50.0%
|
$90,000
$6.55 P/Share
|
|
Feb 17
2021
|
Julie Rubinstein President |
SELL
Open market or private sale
|
Direct |
15,000
-67.34%
|
$915,000
$61.96 P/Share
|
|
Feb 17
2021
|
Julie Rubinstein President |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+50.0%
|
$90,000
$6.55 P/Share
|
|
Feb 16
2021
|
Sharon Benzeno Chief Commercial Ofc Imm Med |
SELL
Open market or private sale
|
Direct |
16,250
-48.68%
|
$1,040,000
$64.43 P/Share
|
|
Feb 16
2021
|
Sharon Benzeno Chief Commercial Ofc Imm Med |
BUY
Exercise of conversion of derivative security
|
Direct |
16,250
+50.0%
|
$503,750
$31.71 P/Share
|
|
Feb 16
2021
|
Stacy L Taylor SVP and General Counsel |
SELL
Open market or private sale
|
Direct |
16,250
-44.05%
|
$1,040,000
$64.43 P/Share
|
|
Feb 16
2021
|
Stacy L Taylor SVP and General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
16,250
+48.08%
|
$503,750
$31.71 P/Share
|
|
Feb 16
2021
|
Francis Lo Chief People Officer |
SELL
Open market or private sale
|
Direct |
2,000
-100.0%
|
$130,000
$65.45 P/Share
|
|
Feb 16
2021
|
Francis Lo Chief People Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,000
+50.0%
|
$14,000
$7.8 P/Share
|
|
Feb 16
2021
|
Robert Hershberg Director |
SELL
Open market or private sale
|
Direct |
2,000
-57.08%
|
$130,000
$65.45 P/Share
|
|
Feb 16
2021
|
Robert Hershberg Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,000
+36.34%
|
$0
$0.45 P/Share
|
|
Feb 16
2021
|
Julie Rubinstein President |
SELL
Open market or private sale
|
Direct |
15,000
-55.66%
|
$975,000
$65.04 P/Share
|
|
Feb 16
2021
|
Julie Rubinstein President |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+50.0%
|
$90,000
$6.55 P/Share
|
|
Feb 16
2021
|
Michelle Renee Griffin Director |
SELL
Open market or private sale
|
Direct |
6,000
-79.96%
|
$390,000
$65.08 P/Share
|
|
Feb 16
2021
|
Michelle Renee Griffin Director |
BUY
Exercise of conversion of derivative security
|
Direct |
6,000
+44.43%
|
$42,000
$7.8 P/Share
|
|
Feb 15
2021
|
David E. Goel Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,504
+50.0%
|
-
|
|
Feb 14
2021
|
Michael J Pellini Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,504
+50.0%
|
-
|
|
Feb 14
2021
|
Kevin T Conroy Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,504
+50.0%
|
-
|
|
Feb 14
2021
|
Robert Hershberg Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,504
+50.0%
|
-
|
|
Feb 14
2021
|
Peter M Neupert Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,504
+50.0%
|
-
|
|
Feb 14
2021
|
Eric Dobmeier Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,504
+50.0%
|
-
|
|
Feb 14
2021
|
Michelle Renee Griffin Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,504
+50.0%
|
-
|
|
Feb 12
2021
|
Julie Rubinstein President |
SELL
Open market or private sale
|
Direct |
15,000
-58.49%
|
$975,000
$65.87 P/Share
|
|
Feb 12
2021
|
Julie Rubinstein President |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+50.0%
|
$90,000
$6.55 P/Share
|
|
Feb 11
2021
|
Julie Rubinstein President |
SELL
Open market or private sale
|
Direct |
15,000
-85.76%
|
$945,000
$63.39 P/Share
|
|
Feb 11
2021
|
Julie Rubinstein President |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+50.0%
|
$90,000
$6.55 P/Share
|
|
Feb 10
2021
|
Julie Rubinstein President |
SELL
Open market or private sale
|
Direct |
15,000
-69.37%
|
$945,000
$63.5 P/Share
|
|
Feb 10
2021
|
Julie Rubinstein President |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+50.0%
|
$90,000
$6.55 P/Share
|
|
Feb 10
2021
|
Chad M Robins CEO and Chairman |
SELL
Open market or private sale
|
Direct |
10,000
-0.15%
|
$620,000
$62.9 P/Share
|
|
Feb 09
2021
|
Julie Rubinstein President |
SELL
Open market or private sale
|
Direct |
15,000
-75.37%
|
$930,000
$62.42 P/Share
|
|
Feb 09
2021
|
Julie Rubinstein President |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+37.5%
|
$90,000
$6.44 P/Share
|
|
Feb 09
2021
|
Chad M Robins CEO and Chairman |
SELL
Open market or private sale
|
Direct |
10,000
-0.29%
|
$620,000
$62.65 P/Share
|
|
Feb 08
2021
|
Julie Rubinstein President |
SELL
Open market or private sale
|
Direct |
15,000
-85.52%
|
$930,000
$62.2 P/Share
|
|
Feb 08
2021
|
Julie Rubinstein President |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+50.0%
|
$90,000
$6.32 P/Share
|